Establishment of a system in which type VII collagen and laminin 5 or their genes are continuously delivered from the dermal side to the basement membrane zone
建立将VII型胶原蛋白和层粘连蛋白5或其基因从真皮侧连续输送至基底膜区的系统
基本信息
- 批准号:15390337
- 负责人:
- 金额:$ 9.41万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2004
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Epidermolysis bullosa is caused by mutations in the genes encoding structural proteins of basement membrane zone. Especially, the subtypes resulting from type VII collagen and laminin 5 genes showed severe phenotype and low quality of life. These structural proteins are thought to be produced by epidermal keratinocytes. Many dermatological investigators intend to introduce the causative genes to keratinocytes and to supply those gene products to basement membrane. The aim of this study was to establish a system in which type VII collagen and laminin 5 or their genes were continuously delivered from the dermal side to the basement membrane zone. We succeeded in purification of a large amount of recombinant type VII collagen last year. The injection of the protein induced deposition of type VII collagen in the basement membrane zone. Also injection of gene-transferred fibroblasts enabled type VII collagen to go into the basement membrane. Furthermore, implantation of these fibroblasts in scaffold increased the amount of type VII collagen in the basement membrane zone. Thus, we think that we can achieve establishment of the system in which type VII collagen and laminin 5 or their genes are continuously delivered from the dermal side to the basement membrane zone.
大疱性表皮病是由编码基底膜带结构蛋白的基因突变引起的。尤其是由VII型胶原和层粘连蛋白5基因引起的亚型表现出严重的表型和低生活质量。这些结构蛋白被认为是由表皮角质形成细胞产生的。许多皮肤病学研究者试图将致病基因导入角质形成细胞,并将这些基因产物提供给基底膜。本研究的目的是建立一个系统,在该系统中,VII型胶原和层粘连蛋白5或其基因从真皮侧连续递送到基底膜区。去年,我们成功地纯化了大量的重组VII型胶原蛋白。注射的蛋白质诱导沉积的VII型胶原在基底膜区。此外,注射基因转移的成纤维细胞使VII型胶原蛋白进入基底膜。此外,这些成纤维细胞在支架中的植入增加了基底膜区中的VII型胶原的量。因此,我们认为我们可以实现VII型胶原和层粘连蛋白5或它们的基因从真皮侧连续递送到基底膜区的系统的建立。
项目成果
期刊论文数量(53)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Keratotic lesions in epidermolysis bullosa simplex with mottled pigmentation.
单纯性大疱性表皮松解症的角化病变伴有斑驳色素沉着。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Toki T;Katsuoka F;Ito E et al.;J.Sasaki;Nakamura H;T.Wada;Yasukawa K
- 通讯作者:Yasukawa K
Keratinocyte-specific modulation of type VII collagen gene expression by pro-inflammatory cytokines (tumor necrosis factor- and interleukin-1).
促炎细胞因子(肿瘤坏死因子和白细胞介素 1)对 VII 型胶原蛋白基因表达的角质形成细胞特异性调节。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:Takeda H;et al.
- 通讯作者:et al.
Sawamura D, et al.: "Identification of COL7A1 alternative splicing inserting 9 amino acid residues into the fibronectin type III linker domain."J Invest Dermatol. 120. 942-948 (2003)
Sawamura D 等人:“鉴定将 9 个氨基酸残基插入纤连蛋白 III 型接头结构域的 COL7A1 选择性剪接。”J Invest Dermatol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sasaki H, et al.: "A novel Sp 1-family-related cis-acting element for transcription of type VII collagen gene (COL7A1)"J Dermaol Sci. 32. 239-242 (2003)
Sasaki H 等人:“用于 VII 型胶原蛋白基因 (COL7A1) 转录的新型 Sp 1 家族相关顺式作用元件”J Dermaol Sci。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Beta defensin-3 engineered epidermis shows highly protective effect for bacterial infection
- DOI:10.1038/sj.gt.3302472
- 发表时间:2005-05-01
- 期刊:
- 影响因子:5.1
- 作者:Sawamura, D;Goto, M;Shimizu, H
- 通讯作者:Shimizu, H
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SAWAMURA Daisuke其他文献
Characterization of Melanin Radicals in Paraffin-embedded Malignant Melanoma and Nevus Pigmentosus Using X-band EPR and EPR Imaging
使用 X 波段 EPR 和 EPR 成像表征石蜡包埋的恶性黑色素瘤和色素痣中的黑色素自由基
- DOI:
10.2116/analsci.33.1357 - 发表时间:
2017 - 期刊:
- 影响因子:1.6
- 作者:
NAKAGAWA Kouichi;MINAKAWA Satoko;SAWAMURA Daisuke;HARA Hideyuki - 通讯作者:
HARA Hideyuki
SAWAMURA Daisuke的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SAWAMURA Daisuke', 18)}}的其他基金
Immunochromatographic method using the salive for rapid diagnosis of bullous pemhigoid
唾液免疫层析法快速诊断大疱性类天疱疮
- 批准号:
16K15541 - 财政年份:2016
- 资助金额:
$ 9.41万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Induction of aoutoantibodies to BP230 and analysis of new function of BP230 using gene-engineered mouse
利用基因工程小鼠诱导BP230自身抗体并分析BP230的新功能
- 批准号:
26293254 - 财政年份:2014
- 资助金额:
$ 9.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of molecular mechanisms switching from TRPV3 gene abnormalities to palmoplantar keratoderma.
TRPV3基因异常转变为掌跖角化症的分子机制分析。
- 批准号:
25670497 - 财政年份:2013
- 资助金额:
$ 9.41万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Establishment of method using spin labeling that evaluates function and structure of lipids between corneal layers.
建立使用自旋标记评估角膜层之间脂质的功能和结构的方法。
- 批准号:
24659518 - 财政年份:2012
- 资助金额:
$ 9.41万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of a new murine system to degrade target proteins rapidly
开发一种新的小鼠系统来快速降解目标蛋白
- 批准号:
23390279 - 财政年份:2011
- 资助金额:
$ 9.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Animal model for dystrophic epidermolysis bullosa and acquired epidermolysis bullosa using genetically engineered mice of type VII collagen
使用VII型胶原基因工程小鼠建立营养不良性大疱性表皮松解症和获得性大疱性表皮松解症动物模型
- 批准号:
20390305 - 财政年份:2008
- 资助金额:
$ 9.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Pathogenecity of autoantibody in bullous pemphigoid and development of epitope-decoy therapy
大疱性类天疱疮自身抗体的致病性及表位诱饵疗法的进展
- 批准号:
18390309 - 财政年份:2006
- 资助金额:
$ 9.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Fundamental study of gene therapy for epidermolysis bullosa : Development of gene therapy targeting keratinocyte
大疱性表皮松解症基因治疗的基础研究:针对角质形成细胞的基因治疗的开发
- 批准号:
08670941 - 财政年份:1996
- 资助金额:
$ 9.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterization of 5 prime flanking region of 230 kDa bullous pemphigoid antigen gene
230 kDa 大疱性类天疱疮抗原基因 5 主要侧翼区域的表征
- 批准号:
05670718 - 财政年份:1993
- 资助金额:
$ 9.41万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
神経線維症1型脊椎病変における椎体dystrophic changeの病態解明
神经纤维化1型脊柱病变椎体营养不良改变的病理学阐明
- 批准号:
24K12333 - 财政年份:2024
- 资助金额:
$ 9.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
糖鎖を狙った損傷軸索治療薬と糖鎖への軸索応答に関する研究基盤の独創
创建针对糖链和轴突对糖链反应的受损轴突治疗药物的研究平台
- 批准号:
23K06829 - 财政年份:2023
- 资助金额:
$ 9.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study of the Safety, Tolerability, and Efficacy of an iPS Cell-based Therapy for Recessive Dystrophic Epidermolysis Bullosa Delivered with a Spray on Skin Device
使用皮肤喷雾装置治疗隐性营养不良性大疱性表皮松解症的 iPS 细胞疗法的安全性、耐受性和有效性研究
- 批准号:
10721324 - 财政年份:2023
- 资助金额:
$ 9.41万 - 项目类别:
Altered nucleus-cytoskeleton coupling in dystrophic muscle
营养不良性肌肉中核-细胞骨架耦合的改变
- 批准号:
10615087 - 财政年份:2023
- 资助金额:
$ 9.41万 - 项目类别:
TRPC6 inhibition therapy to rescue cardiac muscle dysfunction in muscular dystrophy
TRPC6 抑制疗法可挽救肌营养不良症患者的心肌功能障碍
- 批准号:
10541224 - 财政年份:2022
- 资助金额:
$ 9.41万 - 项目类别:
Defective lysosome acidification in dystrophic neurites in Alzheimer's disease contributes to failure of autophagy
阿尔茨海默病营养不良的神经突中溶酶体酸化缺陷导致自噬失败
- 批准号:
10670489 - 财政年份:2022
- 资助金额:
$ 9.41万 - 项目类别:
Progressive loading of a human dystrophic cardiomyopathy 3D model to mimic disease and evaluate therapeutic
逐步加载人类营养不良性心肌病 3D 模型以模拟疾病并评估治疗效果
- 批准号:
10673143 - 财政年份:2022
- 资助金额:
$ 9.41万 - 项目类别:
Epigenetic predisposition and pathogenic mechanisms of recessive dystrophic epidermolysis bullosa
隐性营养不良性大疱性表皮松解症的表观遗传倾向和致病机制
- 批准号:
10673176 - 财政年份:2022
- 资助金额:
$ 9.41万 - 项目类别:
Progressive loading of a human dystrophic cardiomyopathy 3D model to mimic disease and evaluate therapeutic
逐步加载人类营养不良性心肌病 3D 模型以模拟疾病并评估治疗效果
- 批准号:
10507078 - 财政年份:2022
- 资助金额:
$ 9.41万 - 项目类别:
TRPC6 inhibition therapy to rescue cardiac muscle dysfunction in muscular dystrophy
TRPC6 抑制疗法可挽救肌营养不良症患者的心肌功能障碍
- 批准号:
10370853 - 财政年份:2022
- 资助金额:
$ 9.41万 - 项目类别: